TNF-α inhibitors and rheumatoid arthritis

Expert Opinion on Therapeutic Patents

Volumn 8, Issue 5, 1998, Pages 531-544

  Shire, M G ^a   Muller, G W ^a  

^a CELGENE CORPORATION   (United States)

Author keywords

Anti inflammatory; Matrix metalloproteinase; MMP; PDE; Phosphodiesterase; Rheumatoid arthritis; TACE; Thalidomide; TNF converting enzyme; TNF ; Tumour necrosis factor

Indexed keywords

ANTIRHEUMATIC AGENT; MATRIX METALLOPROTEINASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; PHOSPHODIESTERASE IV INHIBITOR; PICLAMILAST; ROLIPRAM; ROLIPRAM DERIVATIVE; THALIDOMIDE; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA; XANTHINE DERIVATIVE;

DRUG DEVELOPMENT; HUMAN; NONHUMAN; PATENT; PUBLICATION; REVIEW; RHEUMATOID ARTHRITIS; STRUCTURE ACTIVITY RELATION;

EID: 0031896013     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.8.5.531     Document Type: Review

References (48)